The Association Between Immune Checkpoint or BRAF/MEK Inhibitor Therapy and Uveitis in Patients With Advanced Cutaneous Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Association Between Immune Checkpoint or BRAF/MEK Inhibitor Therapy and Uveitis in Patients With Advanced Cutaneous Melanoma
Eur. J. Cancer 2021 Feb 01;144(xx)215-223, F Dimitriou, U Urner-Bloch, C Eggenschwiler, N Mitsakakis, J Mangana, R Dummer, M UrnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.